Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
RespireRx Pharmaceuticals (RSPI)
OTHER OTC:RSPI
RespireRx Pharmaceuticals (RSPI) Financial Statements
17 Followers
RespireRx Pharmaceuticals Financial Overview
| Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | - | $ 0.00 | $ 0.00 |
| Gross Profit | - | - | $ 339.60K | - | - |
| EBIT | $ -455.98K | $ 417.96K | $ -219.68K | $ -377.94K | $ -300.77K |
| EBITDA | - | $ 424.50K | $ -211.15K | $ -377.94K | $ -300.77K |
| Net Income Common Stockholders | $ -691.79K | $ 350.69K | $ -639.63K | $ -1.64M | $ -832.03K |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 7.32K | $ 138.00 | $ 88.00 | $ 60.00 | $ 21.00 |
| Total Assets | $ 141.28K | $ 95.89K | $ 22.78K | $ 50.60K | $ 77.71K |
| Total Debt | $ 60.48K | $ 96.41K | $ 2.33M | $ 2.56M | $ 2.42M |
| Net Debt | $ 53.16K | $ 96.27K | $ 2.33M | $ 2.56M | $ 2.42M |
| Total Liabilities | $ 12.28M | $ 12.41M | $ 11.90M | $ 11.64M | $ 11.21M |
| Stockholders Equity | $ -12.14M | $ -12.31M | $ -11.88M | $ -11.59M | $ -11.13M |
| Cash Flow | - | ||||
| Free Cash Flow | - | $ -29.19K | $ 11.16K | $ -69.94K | $ -61.99K |
| Operating Cash Flow | $ -128.58K | $ -29.19K | $ 11.16K | $ -69.94K | $ -61.99K |
| Investing Cash Flow | - | - | - | - | - |
| Financing Cash Flow | $ 135.76K | $ 29.24K | $ -11.13K | $ 69.98K | $ 61.76K |
RespireRx Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.